| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016009 |
| Receipt No. | R000018605 |
| Official scientific title of the study | The study of the efficiency of Keishibukuryogankayokuinin on acne vulgaris. |
| Date of disclosure of the study information | 2014/12/19 |
| Last modified on | 2016/11/01 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The study of the efficiency of
Keishibukuryogankayokuinin on acne vulgaris. |
|
| Title of the study (Brief title) | The study of the efficiency of
Keishibukuryogankayokuinin on acne vulgaris. |
|
| Region |
|
|
| Condition | ||
| Condition | Acne vulgaris | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate efficiency of Keishibukuryogankayokuinin in acne patients. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The decrement of inflammatory of acne lesions
The decrement of non-inflammatory of acne lesions Patients QOL(SKINDEX-16,Syndromes presenting indefinite complaints) Patients satisfaction(Visual analog scale) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The treatment with medicine for external use with Oral Administration of keishibukuryogankayokuinin(2.5g t.i.d before meals)for 12 weeks. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1)Patients who have inflammatory of acne lesions more than 6 counts on one side of their faces.
2)Patients for whom oral administration was possible. 3)Patients who agreed with their written informed consent |
|||
| Key exclusion criteria | 1)Patients with serious complications (liver,kidney,heart,blood,or metabolic disorders)
2)Steroid acne,Drug-induced acne, Necrotizing acne, Occupational acne. 3)Patients who administrated steroid drugs on their whole body. 4)Women who are pregnant, might be pregnamt or lactating or planning a pregnancy. 5)Patients who received drugs prohibited for concomitant use within 1 week before the registration of this study. 6)Patients who participated in clinical trial within 1 month before the registration of this study. 7)Patients taking or planning chemical treatment or laser treatment in this study period. 8)Patients with history of hypersensitivity to traditional Japanese medicine. 9)Patients considered inappropriate by the study investigator |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Toshitatsu Nogita |
| Organization | Shinjuku Minamiguchi Dermatology Skin Clinic |
| Division name | Director |
| Address | 1-18-7 Nishishinjyuku Shinjyuku-ku Tokyo, Japan |
| TEL | 03-3343-4103 |
| nogita@hifuka.com | |
| Public contact | |
| Name of contact person | Toshitatsu Nogita |
| Organization | Shinjuku Minamiguchi Dermatology Skin Clinic |
| Division name | Director |
| Address | 1-18-7 Nishishinjyuku Shinjyuku-ku Tokyo, Japan |
| TEL | 03-3343-4103 |
| Homepage URL | |
| nogita@hifuka.com | |
| Sponsor | |
| Institute | Shinjuku Minamiguchi Dermatology Skin Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | TSUMURA & CO. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018605 |